Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations

Open access

Abstract

BACKGROUND: Congenital hypogonadotropic hypogonadism (HH) is a rare cause for delayed or absent puberty. These patients may recover from HH spontaneously in adulthood. To date, it is not possible to predict who will undergo HH reversal later in life. Herein we investigated whether Finnish patients with reversal of congenital hypogonadotropic hypogonadism (HH) have common phenotypic or genotypic features. METHODS AND FINDINGS: Thirty-two male HH patients with anosmia/hyposmia (Kallmann Syndrome, KS; n = 26) or normal sense of smell (nHH; n = 6) were enrolled (age range, 18-61 yrs). The patients were clinically examined, and reversal of HH was assessed after treatment withdrawal. KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, TACR3, and LHβ were screened for mutations. Six HH patients (2 KS, 4 nHH) were verified to have reversal of HH. In the majority of cases, reversal occurred early in adulthood (median age, 23 yrs; range, 21-39 yrs). All had spontaneous testicular growth while on testosterone replacement therapy (TRT). One nHH subject was restarted on TRT due to a decline in serum T. Two reversal variants had a same GNRHR mutation (R262Q), which was accompanied by another GNRHR mutation (R139H or del309F). In addition, both of the KS patients had a mutation in CHD7 (p.Q51X) or FGFR1 (c.91+2T>A). CONCLUSIONS: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0039450

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Assessment of the reversal of congenital hypogonadotropic hypogonadism (HH). Mean testicular volumes of HH patients were measured at the time of the diagnosis (solid circles) and at participation in the current study (small line). We used the value 2 mL for testicular volumes for cases #2, #6, #7, and #19 at diagnosis, because volumes were estimated to be “small" or “prepubertal" in medical records. Cases #21–25 were previously treated with recombinant-FSH and hCG to induce spermatogenesis. Seven patients (cases #1, 4, 6–9, and 26) discontinued hormone therapy, and 6 (cases #1–6) showed reversal of HH (4 during the treatment pause and 2 without TRT). In addition, #11, 13, 18, and 21 had spontaneous testis growth but they refused to discontinue TRT.
Figure 1 Assessment of the reversal of congenital hypogonadotropic hypogonadism (HH). Mean testicular volumes of HH patients were measured at the time of the diagnosis (solid circles) and at participation in the current study (small line). We used the value 2 mL for testicular volumes for cases #2, #6, #7, and #19 at diagnosis, because volumes were estimated to be “small" or “prepubertal" in medical records. Cases #21–25 were previously treated with recombinant-FSH and hCG to induce spermatogenesis. Seven patients (cases #1, 4, 6–9, and 26) discontinued hormone therapy, and 6 (cases #1–6) showed reversal of HH (4 during the treatment pause and 2 without TRT). In addition, #11, 13, 18, and 21 had spontaneous testis growth but they refused to discontinue TRT.CC BY · PubMed Central
Figure 2 Schematic depicting time of diagnosis, treatment history, and reversal in 6 men with congenital hypogonadotropic hypogonadism.
Figure 2 Schematic depicting time of diagnosis, treatment history, and reversal in 6 men with congenital hypogonadotropic hypogonadism.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. I Rezvani, 1975, Delayed puberty and anosmia; coincidence or Kallmann variant?, Pediatr Res, 9, 224

Cited by

See all 97

Metadata

Authors
Laitinen, E.-M., Tommiska, J., Sane, T., Vaaralahti, K., Toppari, J., & Raivio, T.
Affiliations
  • University of Helsinki (FI)
  • Helsinki University Hospital (FI)
  • University of Turku (FI)
Corresponding author
Raivio, Taneli
Venue
PLoS ONE
Published
2012-06-19
Volume
7
Issue
6
Pages
e39450
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1982199134
Cited by
89
References
39
Citations by year
2025: 2 · 2024: 3 · 2023: 6 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 6 · 2018: 4 · 2017: 7 · 2016: 8 · 2015: 14 · 2014: 14 · 2013: 3 · 2012: 2
FWCI
12.33
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Helsingin Yliopisto
  • Helsingin ja Uudenmaan Sairaanhoitopiiri
  • Suomen Kulttuurirahasto
  • Emil Aaltosen Säätiö
  • Lastentautien Tutkimussäätiö
  • Helsingin Yliopiston Tiedesäätiö
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords
congenital hypogonadotropic hypogonadism, Kallmann syndrome, anosmia, CHD7 mutations, FGFR1 mutation, testosterone replacement therapy, puberty onset, Finnish patients
MeSH terms
Adolescent, Adult, DNA Helicases, DNA-Binding Proteins, Genotype, Humans, Hypogonadism, Male, Mutation, Phenotype, Receptors, LHRH, Kallmann Syndrome, Hormone Replacement Therapy, Receptor, Fibroblast Growth Factor, Type 1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations. https://app.cochat.ai/papers/10.1371/journal.pone.0039450
The paper
Laitinen, E.-M., Tommiska, J., Sane, T., Vaaralahti, K., Toppari, J., & Raivio, T. (2012). Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations. PLoS ONE. https://doi.org/10.1371/journal.pone.0039450

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.